Healthcare -
Biotechnology - NASDAQ - US
$ 9.235
-2.69 %
$ 2.84 B
Market Cap
-51.31
P/E
FOLD - CAPITAL EXPENDITURES
Capital Expenditures FOLD - Amicus Therapeutics, Inc.
-3.55 M
LAST VALUE
2.87%
2 YEAR CAGR
29.23%
5 YEAR CAGR
-31.04%
10 YEAR CAGR